Liang M, et al. - This study assessed the incidence of contrast-induced nephropathy (CIN) in association with short-term use of alprostadil in patients undergoing elective percutaneous coronary intervention (PCI). Findings demonstrated that CIN may be prevented by prophylactic administration of alprostadil in this patient population, specifically in high-risk patients with diabetes mellitus.